(Q42986524)

English

Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction

scientific article published on January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Yukari Takao

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akira Yamada

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shigeru Yutani

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michio Sata

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kyogo Itoh

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

507-517

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Synthetic peptide-based immunoassay as a supplemental test for HCV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Perspectives: towards a peptide-based vaccine against hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

IgG reactive to CTL‐directed epitopes of self‐antigens is either lacking or unbalanced in atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Cellular immune responses against hepatitis C virus: the evidence base 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2004.TB03546.X

21 January 2018

Identifiers

10.1111/J.1348-0421.2004.TB03546.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42986524&oldid=1975876601"